Target intelligence / Profile preview

syndecan binding protein 2 pseudogene 1 (SDCBP2P1)

Target
SDCBP2P1
Molecular classification
pseudogene
01

Overview

Syndecan binding protein 2 pseudogene 1 (SDCBP2P1) is a genomic DNA sequence classified as a pseudogene—a non-coding counterpart of the functional gene SDCBP2 (syndecan binding protein 2)[5]. It does not produce an active protein. The functional gene SDCBP2 encodes a protein containing PDZ domains involved in nuclear PIP2 organization, cell division, and cell survival[7], but SDCBP2P1 only resembles its sequence and is not actively translated or part of a receptor, enzyme, transporter, or known therapeutic target pathway. Its presence is primarily relevant in the context of genomic studies, annotation, and evolutionary biology, not in drug discovery or disease targeting[5]. In summary: SDCBP2P1 is not considered a molecular target. It is a pseudogene and does not encode a receptor, enzyme, or other druggable entity[5][7]. There are no known biological functions or disease involvements attributed to this sequence[5].

Other names
syndecan binding protein (syntenin) 2 pseudogene 1SDCBP2P1
02

Mechanism of action

None; as a pseudogene, it does not encode a protein that interacts with drugs.

03

Biological functions

None; pseudogenes do not encode functional proteins or have direct biological roles[5].
04

Disease associations

None known; no direct association with disease as it lacks coding potential[5].
05

Safety considerations

None; not therapeutically targeted.
06

Interacting drugs

None; as a pseudogene, it does not encode a protein that interacts with drugs.
07

Biomarkers

None; not used for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on syndecan binding protein 2 pseudogene 1 (SDCBP2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on syndecan binding protein 2 pseudogene 1 (SDCBP2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call